12/09/2024
6:39 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:33 PM | Paradigm Biocapital Advisors LP (Filed by)
Vor Biopharma (Subject)
| Form SC 13G/A | |
11/08/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2024
3:20 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/05/2024
3:15 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:15 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
3:16 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2024
3:17 PM | Choi Han Wook (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
6:05 AM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:06 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:01 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:29 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:30 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
4:04 PM | Jorgensen Nathan D. (Reporting)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
4:22 PM | Quinlan Amy (Reporting)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/04/2024
5:09 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:38 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
3:54 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:10 PM | Lundberg Sven Ante (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:10 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:10 PM | Patterson Matthew R (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:10 PM | Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:40 PM | Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
3:39 PM | Namouni Fouad (Reporting)
Vor Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/09/2024
3:05 PM | Vor Biopharma (Filer)
| Form DEF 14A | |
04/09/2024
3:07 PM | Vor Biopharma (Filer)
| Form DEFA14A | |
04/09/2024
3:10 PM | Vor Biopharma (Filer)
| Form ARS | |
02/08/2024
4:10 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
4:05 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
4:06 PM | Jorgensen Nathan D. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
4:08 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:38 PM | Attar Eyal C. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:34 PM | Jorgensen Nathan D. (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:35 PM | ANG ROBERT (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
6:36 PM | Chakraborty Tirtha (Reporting)
Vor Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
4:03 PM | Vor Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
